All News about Amphastar Pharma
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_6081.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2641.jpeg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/26702.png?v=0)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU1.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](https://investorplace.com/wp-content/uploads/2022/03/domino-money-stability-1600.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2685.jpeg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/26702.png?v=0)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/ep_us_feature_image_1366.jpeg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/26702.png?v=0)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech5_2.jpg)
![](https://investorplace.com/wp-content/uploads/2022/02/piggybank_safe_1600.png)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_381.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_1814.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_111.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/26702.png?v=0)
Amphastar Receives FDA Tentative Approval for Vasopressin
December 29, 2021
Via AccessWire
Exposures
Product Safety
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_693.jpeg?width=720)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/26702.png?v=0)
![](https://www.investors.com/wp-content/uploads/2017/03/stock-pharmaceutical-2-adobe.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/26702.png?v=0)
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
November 11, 2021
Via AccessWire
Topics
Regulatory Compliance
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
Amphastar Pharmaceuticals, inc (AMPH) Q3 2021 Earnings Call Transcript
November 08, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/earnings_image_645.jpeg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.